Investing News 4 November 2025

Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Company Overview: A Self-Care Healthcare Player Perrigo Company plc is a consumer healthcare and self-care products company with over a century of history in the OTC medicine space Perrigo. Now domiciled in Dublin, Ireland (with major operations in the U.S.

5 November 2025

Company Analysis·Financial News·Investing·Market Trends·Stock Market

Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Company Overview: Business Model & Background Rubico Inc. is a Marshall Islands-incorporated shipping company providing crude oil transportation services via a small fleet of tankers Globenewswire Globenewswire. The company was created as a spin-off from TOP Ships Inc., a Greek

5 November 2025

Company Analysis·Financial News·Investing·Stock Market

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Market Performance and Recent Stock Price Trex stock has endured a steep slide in 2025, culminating in a dramatic plunge after its early November earnings announcement. On November 5, 2025, TREX opened around $34–35 per share – down roughly 26%

5 November 2025

Business Analysis·Earnings Reports·Home Improvement·Investing·Stock Market

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Company Overview: AI-Powered Biotech at the Intersection of Therapeutics & Biodefense Lunai Bioworks Inc. is a pre-clinical stage biotechnology company pioneering an unusual dual focus: AI-driven drug discovery and biodefense. The company’s mission is to “capture biological signals at scale,

5 November 2025

Biotechnology·Company Analysis·Innovation·Investing·Stock Market

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

FDA Setback: Complete Response Letter Halts Lead Drug Ambitions Biohaven’s recent troubles center on VYGLXIA (troriluzole) – its lead drug candidate for spinocerebellar ataxia (SCA), a degenerative brain disorder that currently has no approved treatment Reuters. On November 4, 2025,

5 November 2025

Biotech·Investing·Pharmaceuticals·Stocks

Plug Power’s Hydrogen Comeback: Why PLUG Stock Skyrocketed 226% – and What’s Next

Business Model and Market Position Plug Power’s business model centers on building a full “hydrogen ecosystem” – from hydrogen production and storage to fuel cell power generation for end-users Investing. The company pioneered the use of hydrogen fuel cell systems

5 November 2025

Green Technology·Investing·Market Analysis·Stocks

The Surprising Upside in CCC Intelligent Solutions (CCCS): Why This Under-the-Radar SaaS Stock Could Soar

Company Background and Business Model CCC Intelligent Solutions Holdings Inc. is a Chicago-based software-as-a-service provider for the property & casualty (P&C) insurance industry. Founded in 1980, CCC has spent decades building a platform that digitizes the insurance claims process –

5 November 2025

Financial Analysis·Investing·Stock Market

Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In

‘Vineland ramp’ or bust? Nebius’ Q3 countdown, Microsoft mega‑deal and stock‑split buzz — what investors need to know now

The big picture Nebius — the Amsterdam‑based AI‑infrastructure company created from Yandex’s non‑Russian assets — has become one of 2025’s most closely watched “neocloud” names. Its Nov. 11 Q3 print arrives amid a volatile week for the stock, but also

5 November 2025

Company News·Financial Analysis·Investing·Stock Market·Tech Industry

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 05.11.2025

ENDEDLive coverage has endedEnded: November 6, 2025, 12:02 AM EST AMC Entertainment (NYSE:AMC) Q3 Revenue Beats, EBITDA Ahead but Margin Pressure Persists November 5, 2025, 11:54 PM EST. AMC Entertainment (NYSE:AMC) posted a mixed Q3. Revenue came in at $1.3

5 November 2025

Finance·Investing·Market Analysis·Stock Market

AMD Stock Skyrockets on AI Mega-Deal – Latest Price, Q3 Earnings Preview & Expert Analysis

AMD Stock Forecast 2025: Will AI Deals Power More Gains or Is It Priced to Perfection?

Current Performance and Valuation AMD’s stock has been on a tear in 2025, significantly outperforming peers. The share price recently hit an all-time high around $243 in late October Investing amid the broader AI-driven tech rally. As of early November

4 November 2025

Artificial Intelligence·Financial Analysis·Investing·Stock Market·Technology

Beyond Meat (BYND) Stock Forecast 2025: Will Plant-Based Meat Sizzle or Fizzle?

Current Stock Price and Performance As of early November 2025, Beyond Meat’s stock is trading in the mid-$1 range per share Stockanalysis. The latest closing price was about $1.39 on Nov 3, 2025 Stockanalysis, a stunning collapse from its peak

4 November 2025

Financial Analysis·Future Trends·Investing·Stock Market

Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

7 Best Stocks to Buy Now for Big Gains (November 2025 Edition)

Key Takeaways Market Overview: Rally Rolls On, With Underlying Risks 2025 has been a banner year for stocks globally. In the U.S., the S&P 500 and Nasdaq have repeatedly notched all-time highs Reuters, fueled by strong corporate earnings (especially in

4 November 2025

Financial Planning·Growth Stocks·Investing·Personal Finance·Stock Market

Investing News 4 November 2025 - 5 November 2025